These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 20308476

  • 1. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA, Tung GA, Grand DJ, Pezzullo JA, Machan JT, Renzulli JF.
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB, Kong X, Niver BE, Berkman DS, Melamed J, Babb JS, Taneja SS.
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [Abstract] [Full Text] [Related]

  • 3. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, Fütterer JJ, van Oort IM, van Basten JP, Karthaus HF, Witjes JA, Barentsz JO.
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [Abstract] [Full Text] [Related]

  • 4. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y, Nakai Y, Matsumoto Y, Samma S, Miyasaka T, Nakagawa H.
    Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
    [Abstract] [Full Text] [Related]

  • 5. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO.
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC, Kuder TA, Kuru TH, Fenchel M, Hadaschik BA, Laun FB, Schlemmer HP, Stieltjes B.
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M.
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [Abstract] [Full Text] [Related]

  • 10. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I, Kim CK, Park BK, Park W.
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F, Ravelli S, Esposito A, Giganti F, Gallina A, Montorsi F, Del Maschio A.
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB, Sigmund EE, Johnson G, Babb JS, Mussi TC, Melamed J, Taneja SS, Lee VS, Jensen JH.
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [Abstract] [Full Text] [Related]

  • 14. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK, Park BK, Kim B.
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB, Kopec M, Kong X, Melamed J, Dakwar G, Babb JS, Taouli B.
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [Abstract] [Full Text] [Related]

  • 17. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.
    Caivano R, Rabasco P, Lotumolo A, Cirillo P, D'Antuono F, Zandolino A, Villonio A, Macarini L, Salvatore M, Cammarota A.
    Cancer Invest; 2013 Nov; 31(9):625-9. PubMed ID: 24138289
    [Abstract] [Full Text] [Related]

  • 18. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T, Ashida S, Yamasaki I, Kuno T, Fukuhara H, Fukata S, Satake H, Tamura K, Karashima T, Kamata M, Inoue K, Shuin T, Kariya S, Ogawa Y.
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [Abstract] [Full Text] [Related]

  • 19. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A, Ajdukovic AN, Fliessbach K, Lehnert T, Engl T, Jacobi V, Vogl TJ.
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K, Takahashi S, Ueno Y, Yoshikawa T, Ohno Y, Obara M, Miyake H, Fujisawa M, Sugimura K.
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.